NEW YORK (GenomeWeb) – Espoo, Finland-based molecular diagnostics firm Orion Diagnostica has launched a Clostridium difficile assay on its CE-marked Orion GenRead platform.
The bench-top assay works direct from stool on up to 12 samples at a time and can detect strongly-positive infections in 15 minutes using a patented isothermal amplification technology, a company representative told GenomeWeb in an email.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
